glp-1 and alcohol use disorder medications: The next big thing in treatment? – Recovery Research Institute GLP-1 Alcohol Cravings: How Ozempic

In spring 2025, the Food and Drug Administration (FDA) resolved and ended the GLP-1 medications shortage, subsequently releasing declaratory orders that neither outsourcing compounding pharmacies or pharmacies could compound drugs that were essentially copies of either semaglutide (available under the brand names Ozempic, Rybelsus, and Wegovy) and tirzepatide (available under the brand names Mounjaro, and Zepbound).

A clinical consultation and eligibility screening are required prior to dispensing

GLP-1 receptor agonists are now used by more than a quarter

See individual product labels for complete exclusion details

Nourish and protect your muscles to stay strong, active, and energized at any age with Ageless Muscle Support